These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16043349)

  • 1. Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment.
    Brenner H; Hakulinen T
    Eur J Cancer; 2005 Aug; 41(12):1788-93. PubMed ID: 16043349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative approach to age adjustment of cancer survival rates.
    Brenner H; Arndt V; Gefeller O; Hakulinen T
    Eur J Cancer; 2004 Oct; 40(15):2317-22. PubMed ID: 15454258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
    Brenner H; Hakulinen T
    Am J Epidemiol; 2006 Oct; 164(7):689-96. PubMed ID: 16840519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial overestimation of standard errors of relative survival rates of cancer patients.
    Brenner H; Hakulinen T
    Am J Epidemiol; 2005 Apr; 161(8):781-6. PubMed ID: 15800271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction for under-ascertainment in cancer cases in the very elderly (aged 75+): external reference method.
    Fallah M; Kharazmi E
    Cancer Causes Control; 2008 Sep; 19(7):739-49. PubMed ID: 18322815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are survival rates for Tyrol published in the Eurocare studies biased?
    Oberaigner W; Siebert U
    Acta Oncol; 2009; 48(7):984-91. PubMed ID: 19714522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
    Brenner H; Söderman B; Hakulinen T
    Int J Epidemiol; 2002 Apr; 31(2):456-62. PubMed ID: 11980816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Period estimates of cancer patient survival are more up-to-date than complete estimates even at comparable levels of precision.
    Brenner H; Hakulinen T
    J Clin Epidemiol; 2006 Jun; 59(6):570-5. PubMed ID: 16713519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model based hybrid analysis of cancer patient survival.
    Brenner H; Hakulinen T
    Eur J Cancer; 2007 Mar; 43(5):921-7. PubMed ID: 17329096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.
    Robinson D; Sankila R; Hakulinen T; Møller H
    Eur J Cancer; 2007 Mar; 43(5):909-13. PubMed ID: 17300929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Greenwood formula for standard error of the age-standardised relative survival ratio.
    Pokhrel A; Dyba T; Hakulinen T
    Eur J Cancer; 2008 Feb; 44(3):441-7. PubMed ID: 18053707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to interpret the relative survival ratios of cancer patients.
    Pokhrel A; Hakulinen T
    Eur J Cancer; 2008 Nov; 44(17):2661-7. PubMed ID: 18819791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival chances of Hungarian cancer patients in the National Cancer Registry].
    Tusnády G; Gaudi I; Rejto L; Kásler M; Szentirmay Z
    Magy Onkol; 2008 Dec; 52(4):339-49. PubMed ID: 19068461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival expectations of cancer patients in Europe in 2000-2002.
    Brenner H; Francisci S; de Angelis R; Marcos-Gragera R; Verdecchia A; Gatta G; Allemani C; Ciccolallo L; Coleman M; Sant M;
    Eur J Cancer; 2009 Apr; 45(6):1028-41. PubMed ID: 19091549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing the benefits of model-based period analysis of cancer patient survival.
    Brenner H; Hakulinen T
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1675-81. PubMed ID: 17684145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States.
    Wu X; Matanoski G; Chen VW; Saraiya M; Coughlin SS; King JB; Tao XG
    Cancer; 2008 Nov; 113(10 Suppl):2873-82. PubMed ID: 18980291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan.
    Tsukuma H; Ajiki W; Ioka A; Oshima A;
    Jpn J Clin Oncol; 2006 Sep; 36(9):602-7. PubMed ID: 16870692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-to-date estimates of cancer patient survival even with common latency in cancer registration.
    Brenner H; Hakulinen T
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1727-32. PubMed ID: 16985036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer survival trends in Osaka, Japan: the influence of age and stage at diagnosis.
    Ito Y; Ohno Y; Rachet B; Coleman MP; Tsukuma H; Oshima A
    Jpn J Clin Oncol; 2007 Jun; 37(6):452-8. PubMed ID: 17635966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.
    Talbäck M; Dickman PW
    Eur J Cancer; 2011 Nov; 47(17):2626-32. PubMed ID: 21924892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.